Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
14.03
-0.25 (-1.75%)
Nov 20, 2026, 3:00 PM CST
| Market Cap | 20.96B -9.0% |
| Revenue (ttm) | 8.00B -4.2% |
| Net Income | 1.22B +11.4% |
| EPS | 0.82 +10.8% |
| Shares Out | 1.49B |
| PE Ratio | 17.12 |
| Forward PE | 9.97 |
| Dividend | 0.34 (2.42%) |
| Ex-Dividend Date | Oct 15, 2026 |
| Volume | 13,342,579 |
| Open | 14.25 |
| Previous Close | 14.28 |
| Day's Range | 13.93 - 14.25 |
| 52-Week Range | 12.90 - 16.24 |
| Beta | 0.21 |
| Analysts | Buy |
| Price Target | 16.73 (+19.24%) |
| Earnings Date | Oct 24, 2026 |